Potestio, L.; Scalvenzi, M.; Lallas, A.; Martora, F.; Guerriero, L.; Fornaro, L.; Marano, L.; Villani, A.
Efficacy and Safety of Cemiplimab for the Management of Non-Melanoma Skin Cancer: A Drug Safety Evaluation. Cancers 2024, 16, 1732.
https://doi.org/10.3390/cancers16091732
AMA Style
Potestio L, Scalvenzi M, Lallas A, Martora F, Guerriero L, Fornaro L, Marano L, Villani A.
Efficacy and Safety of Cemiplimab for the Management of Non-Melanoma Skin Cancer: A Drug Safety Evaluation. Cancers. 2024; 16(9):1732.
https://doi.org/10.3390/cancers16091732
Chicago/Turabian Style
Potestio, Luca, Massimiliano Scalvenzi, Aimilios Lallas, Fabrizio Martora, Luigi Guerriero, Luigi Fornaro, Laura Marano, and Alessia Villani.
2024. "Efficacy and Safety of Cemiplimab for the Management of Non-Melanoma Skin Cancer: A Drug Safety Evaluation" Cancers 16, no. 9: 1732.
https://doi.org/10.3390/cancers16091732
APA Style
Potestio, L., Scalvenzi, M., Lallas, A., Martora, F., Guerriero, L., Fornaro, L., Marano, L., & Villani, A.
(2024). Efficacy and Safety of Cemiplimab for the Management of Non-Melanoma Skin Cancer: A Drug Safety Evaluation. Cancers, 16(9), 1732.
https://doi.org/10.3390/cancers16091732
